Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Trimethoprim-Sulfamethoxazole Effects on the Nasal Microbiome in Granulomatosis With Polyangiitis

NCT03919435 is registered in ClinicalTrials.gov with University of Pennsylvania as lead sponsor.

NCT NCT03919435
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03919435 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Trimethoprim-Sulfamethoxazole Effects on the Nasal Microbiome in Granulomatosis With Polyangiitis
Lead sponsor
University of Pennsylvania
Phase
Phase 1/2
Overall status
Active, not recruiting
Start date
March 27, 2019
Completion date
December 30, 2027
Enrollment
8 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

granulomatosis with polyangiitis, wegener granulomatosis